Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced non-small-cell lung cancer

por Jänne, P A, Smith, I, McWalter, G, Mann, H, Dougherty, B, Walker, J, Orr, M C M, Hodgson, D R, Shaw, A T, Pereira, J R, Jeannin, G, Vansteenkiste, J, Barrios, C H, Franke, F A, Crinò, L, Smith, P
Publicado 2015

Anti-inflammatory and antinociceptive effects of the isatin derivative (Z)-2-(5-chloro-2-oxoindolin-3-ylidene)-N-phenyl-hydrazinecarbothioamide in mice

por Dantas, L.L.S.F.R., Fonseca, A.G., Pereira, J.R., Furtado, A.A., Gomes, P.A.T.M., Fernandes-Pedrosa, M.F., Leite, A.C.L., Rêgo, M.J.B.M., Pitta, M.G.R., Lemos, T.M.A.M.
Publicado 2020